Johnson & Johnson must pay more than $42 million to a Massachusetts man who alleges that he developed mesothelioma, a rare ...

Here are five excellent dividend stocks to consider holding for the next five years.

Johnson & Johnson (JNJ) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

On Tuesday, U.S. District Judge Michael Shipp of the District of New Jersey ruled that the plaintiffs’ steering committee in ...

Johnson & Johnson is still facing many lawsuits that threaten its business. It may face additional challenges from patent ...

Shockwave Medical is clearing the way for Johnson & Johnson MedTech to retake its title as the world's largest medical device ...

Palantir’s eccentric CEO has led one of the most controversial companies in Silicon Valley to unprecedented success.

Johnson & Johnson was at a crossroads. Depending on how executives responded, it could either scare their loyal customers away forever or prove they were a company and a brand to be trusted.

According to Johnson & Johnson’s 2023 Health for Humanity Report, the company sought to have 50% of its management positions held by women and 6.8% of management slots held by Black and African ...

Johnson & Johnson shares surged Wednesday after the company reported second-quarter results that topped estimates and the ...

J&J's stock price is down from its 2022 peak, but it's performed better than you might think by simply looking at its chart. In 2023, shareholders received new shares of Kenvue, which used to be the ...